News
Interview: Phantom uterus aims to revolutionise gynaecological procedures
A biomedical engineer is tackling the painful reality of gynaecological procedures, with a “phantom uterus” that offers a safe, anatomically accurate platform for designing and testing medical devices, with the potential to transform comfort, safety and innovation in women’s healthcare.
Women-specific medical devices have received little attention in science and medical research, resulting in few advancements for decades. Routine procedures such as the insertion of the contraceptive implant often leave women in severe pain or cause them to avoid it altogether.
Almost 90 per cent of women report moderate to severe pain during a cervical procedure for IUD insertion, with 18 per cent using an alternative to IUD for contraception because of fear of how painful they can be.
Biomedical engineer, Saskia Hale, has designed and manufactured a life-sized phantom of a pre-menopausal non-pregnant uterus for the planning and designing of implants.
Long term, the innovation has the potential to improve the design, functionality and safety of medical devices used in gynaecological procedures, by providing an anatomically and mechanically accurate model.
A recent graduate of Biomedical Engineering from Imperial College London, Hale developed the
device as part of her Master’s Project.
It integrates advanced medical imaging, computational modelling, and materials science, enabling safe and effective gynaecological device development and reducing the need for live patient trials.
Developing the phantom uterus
Hale, who says she is passionate about improving the quality of people’s lives, is currently a biomedical engineer with Arete Medical Technologies.
Her idea for the phantom uterus came about after Charing Cross Hospital’s clinical engineering department began developing a device to test the geometry of a mechanically accurate uterus.
“I had an initial meeting with my supervisor, Dr Warren Macdonald, and the hospital to understand more of the specifics and what they wanted from the project to make it meaningful for them,” Hale tells Femtech World.
“I began to learn more about the materials that could replicate the uterus structures. One of the most interesting ways of doing this was not just by looking at journals, but by visiting the hospital’s Cadaver Lab and speaking to anatomy prosectors.
“I took away some great points, regarding not just the uterus, but considering how it interacts with the surrounding organs.
“Early in the design process, I also realised the importance of making the model adaptable to different uterine positions, not just the anteverted position, the most common type. It was really important to me that everyone was represented to improve the experience women have with intrauterine medical devices.”
How it works
The phantom uterus was developed through extensive research to help Hale understand the anatomy of the uterus – segmenting medical images to create a 3D model and exploring the viability of potential materials before the phantom uterus was manufactured and tested.
“The phantom uterus I developed is a model to allow for deployment planning and geometric designing of an implant,” says Hale.
“It works free-standing at the moment, but in the future, I hope to add a pelvis and the surrounding organs as I look towards improvements and the realism of the phantom uterus.
Hale adds, “Any device that can be inserted vaginally into the uterus can be tested to see how it interacts.”
Two key areas of the uterus needed to be validated for the design.
“After careful material selection, which influenced the manufacturing technique, anatomical validation and medical device validation were needed,” Hale explains.
“The anatomical validation showed that the uterus developed was a little bit smaller than expected, possibly due to the scans used and the shrinkage during moulding, needing to be larger than what was accounted for.
“The medical device validation study looked at a speculum being inserted into the phantom uterus and the key things a physician would do, see and feel, and how closely they were mimicked by the uterus. The results showed an 80 per cent performance score, and with some improvements, that score is expected to only go up.”
Supporting unmet need
Women-specific medical devices, such as contraceptive devices, are underfunded and under-researched, Hale highlights, emphasising that the phantom uterus allows for precise testing and optimisation of devices, ensuring they are safe, effective and comfortable for patients.
“A phantom uterus would also address the underfunding in women’s health that has resulted
in gaps in knowledge and treatment options, as a safer method for pre-clinical trials and the redevelopment of devices that may not work effectively,” says Hale, who shared her research at BioMedEng24.
“I’d love to continue furthering the work on the phantom uterus and to share my research so others can learn and progress in medical device design within women’s health.”
Earlier this year, Hale was selected as the winner of the Judge’s Choice Award at the Femtech Awards 2025 for her work on the phantom uterus project, an achievement she describes as a “complete surprise” and “an absolute privilege”.
“This is my life mission,” says Hale. “Being recognised alongside such influential individuals and organisations in the femtech field is incredibly meaningful, especially since I am so early on in my career.”
She adds: “This achievement wouldn’t have been possible without the support of Imperial College London and Charing Cross Hospital, especially my supervisor, Dr. Warren Macdonald, as well as Joelle and Aheed from Charing Cross.”
Events
Research project of the year: What the judges want to see
Submitting your research project for Femtech World Awards recognition can feel daunting.
What makes one project stand out from another?
After reviewing successful submissions from previous years, we’ve identified the key elements that transform good research into award-winning work.
Innovation That Solves Real Problems
Judges aren’t just looking for novelty – they’re looking for innovation that addresses genuine gaps in women’s health.
The best submissions clearly articulate a specific problem and demonstrate how their research offers a fresh approach to solving it.
Ask yourself: Does your research tackle an underserved area? Are you approaching a known problem from a new angle?
The most compelling projects often focus on issues that have been overlooked, understudied or inadequately addressed by existing solutions.
Whether you’re investigating menopause in the workplace, developing better diagnostic tools for endometriosis, or exploring mental health interventions for new mothers, clarity about the problem you’re solving is essential.
Rigorous Methodology
Strong research stands on solid foundations. Judges carefully evaluate your methodology to ensure your findings are credible and reproducible.
This doesn’t mean your research needs to be complete – early-stage projects are welcome – but you should demonstrate thoughtful research design.
Include details about your sample size, data collection methods, controls, and analytical approaches.
If you’re conducting qualitative research, explain how you’re ensuring validity. If you’re building a technological solution, describe your testing protocols.
Transparency about limitations shows intellectual honesty and strengthens rather than weakens your submission.
Measurable Impact Potential
The research projects that win hearts and awards are those with clear pathways to real-world impact.
Judges want to see beyond the research itself to understand how your work will improve women’s lives.
Consider questions like: Who will benefit from this research? How many people could be affected? What would successful implementation look like?
Whether your impact is clinical, social, economic, or policy-related, be specific.
Instead of saying “this will help women,” try “this diagnostic tool could reduce endometriosis diagnosis time from 7-10 years to under 2 years for an estimated 200 million women worldwide.”
Inclusivity and Diversity Considerations
Award-winning FemTech research recognises that women are not a monolith.
Judges increasingly value projects that consider diversity across age, race, ethnicity, socioeconomic status, disability, and geographic location.
Have you thought about how your research applies across different populations? Are you inadvertently excluding certain groups?
The strongest submissions acknowledge these considerations and, where possible, design research to be inclusive or clearly define the specific population being served.
Clear Communication
Even groundbreaking research won’t win if judges can’t understand it. The ability to communicate complex ideas clearly is crucial.
Avoid unnecessary jargon, define technical terms, and structure your submission logically.
Think of your submission as telling a story: Here’s the problem, here’s why it matters, here’s what we did, here’s what we found, and here’s why it matters for the future.
Feasibility and Sustainability
Judges appreciate ambitious research, but they also value realistic plans.
Show that you’ve thought about practical considerations: Do you have the resources to complete this work? Is your timeline reasonable?
For projects seeking commercialisation, is there a viable path to market?
Demonstrating that you’ve considered challenges and have strategies to overcome them shows maturity and increases confidence in your project’s success.
Your Passion Matters
Finally, don’t underestimate the power of genuine passion.
The researchers who win aren’t just technically proficient – they deeply care about their work and its potential to create change.
Let that commitment shine through in your submission.
Ready to submit? Find out more about the awards and enter for free here.
Insight
Topical HRT protects bone density in women with period loss – study
Transdermal HRT best protects bone density in women with functional hypothalamic amenorrhoea, a condition that stops periods, a review of trials has found.
The meta-analysis pooled randomised clinical trials involving 692 participants and found transdermal hormone replacement therapy and teriparatide increased bone mineral density by between 2 and 13 per cent.
Functional hypothalamic amenorrhoea can follow anorexia or intense exercise. Bone mineral density measures bone strength and the amount of mineral in bone.
Around half of women with the condition have low bone mineral density, compared with about 1 per cent of healthy women, and their fracture risk is up to seven times higher.
The research was conducted by scientists at Imperial College London and Imperial College Healthcare NHS Trust.
Professor Alexander Comninos, senior author of the study and consultant endocrinologist at the trust, said: “Bone density is lost very rapidly in FHA and so addressing bone health early is very important to reduce the lifelong risk of fractures.
“Our study provides much needed comparisons of all the available treatments from all available studies.
“Clearly the best treatment is to restore normal menstrual cycles and therefore oestrogen levels through various psychological, nutritional or exercise interventions – but that is not always possible.
“The foundation for bone health is good calcium and vitamin D intake (through diet and/or supplements) but we have additional treatments that are more effective.”
When FHA is diagnosed, clinicians first try to restore periods through lifestyle measures, including psychological and dietary support, but these can fail. Guidelines then recommend giving oestrogen, though the best form was unclear.
The team reviewed all prior randomised trials comparing therapies, including oral and transdermal oestrogen, and also assessed teriparatide, a prescription bone-building drug used for severe osteoporosis.
They found no significant benefit for oral contraceptive pills or oral hormone therapy.
A recent UK audit reported that about a quarter of women with anorexia-related FHA are prescribed the oral contraceptive pill for bone loss; the study suggests using transdermal therapy instead.
Comninos said: “Our goal is simple: to help women receive the right treatment sooner and to protect their bone health in the long-term.
“We hope this study provides clinicians with better evidence to choose transdermal oestrogen when prescribing oestrogen and so inform future practice guidelines.
“Right now, millions of women with FHA may not be receiving the best treatments for their bone health.”
Cancer
AI cuts interval breast cancers in Swedish trial
-
Features4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Features4 weeks agoBest menopause apps and products for 2026
-
Fertility2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Entrepreneur4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Insight3 weeks agoChina’s birth rate hits record low despite government fertility efforts








